Progress Update: Flex fund for clinical study participant reimbursement

See grant Travel Reimbursement for Clinical Study Participants

The purpose of this $10,000 grant was to reimburse study participants for their travel and time costs associated with coming to the clinic and participating in two ongoing clinical studies, one led by Dr. Manda Keller Ross, co-investigator Michael Kyba, focusing on metabolism in FSHD and the other led by Dr. Michael Kyba, focused on studying primary cells from muscle of FSHD patients. To date, we have provided study reimbursements to approximately 40 participants, with $4788.31 remaining. While the metabolic studies are now completed, the biopsy study is still ongoing. During COVID, the biopsy study was actually paused, however Dr. Kyba has recently renewed his IRB protocol and scheduling of new biopsy study participants has begun, thus we envisage spending out the remaining funds in the next 2 years.

Research Output:

The following publications benefited from support from this grant mechanism, i.e., patients were reimbursed for study participation costs and the grant from Friends of FSH Research was attributed in the funding section of the papers:

Vera K, McConville M, Kyba M, Keller-Ross M. Sarcopenic obesity in facioscapulohumeral muscular dystrophy. (2020) Frontiers in Physiology. 11:1008

Vera K, McConville M, Kyba M, Keller-Ross M. Resting metabolic rate in adults with facioscapulohumeral muscular dystrophy. (2021) Applied Physiology, Nutrition, and Metabolism 46:1058-1064.

Vera K, McConville M, Glazos A, Stokes W, Kyba M, Keller-Ross M. Exercise intolerance in facioscapulohumeral muscular dystrophy. (2022) Med Sci Sports Exerc 54:887-895.

Anselmo M, Coffman S, Larson M, Vera K, Lee E, McConville M, Kyba M, Keller‐Ross ML. Baroreflex sensitivity in facioscapulohumeral muscular dystrophy. (2022) Physiological Reports. 10:e15277.